Pulmatrix, Inc.
- PULM
- NASDAQ
- Biotechnology
- Inhaled Therapeutics
- Respiratory Drug Development
- iSPERSE Platform
$1.36
Today −3.55%Quote Oct 16, 2026, 08:00 PM UTC
−4.90%over the last month
Max drawdown −20.0%From 1-month high −20.0%3 months −19.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.0M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.36
0.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PULMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
2